HLA-haploidentical allogeneic blood or bone-marrow transplantation (haploBMT) has historically been associated with poor outcomes, owing to high rates of graft failure and graft-versus-host disease ...

HLA-Arena can be integrated in computational pipelines to support basic cancer research or to help inform physicians in preclinical settings. It can be used to perform structure-based selection of ...